Medical Condition

glaucoma

Total Trials

14

Recruiting Now

14

Trial Phases

Phase 3, Phase 2, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for glaucoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — glaucoma Clinical Trials

How many clinical trials are currently recruiting for glaucoma?

ClinicalMetric currently tracks 14 actively recruiting clinical trials for glaucoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for glaucoma?

glaucoma research spans Phase 2 (3 trials), Phase 3 (2 trials), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a glaucoma clinical trial?

Eligibility criteria for glaucoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Phase 3

Phase 4

Top Sponsors

Glaukos Corporation 2 trials

Stanford University 2 trials

Christopher Kai Shun Leung 2 trials

McGill University Health Centre/Research Institute of the McGill University Health Centre 1 trial

Medical University of Graz 1 trial

Recruiting Clinical Trials

NCT07495852 Phase 3

Recruiting

Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Electrical Stimulation for Vision Neuroenhancement in Glaucoma

This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.

McGill University Health Centr...

View Trial →

NCT05426044 Phase 2

Recruiting

Metformin as a Neuroprotective Therapy for Glaucoma

Christopher Kai Shun Leung

View Trial →

NCT06844292

Recruiting

Evaluation of Microinvasive Glaucoma Surgery: MINIject® Versus Hydrus® Microstent in Combination With Cataract Surgery

Medical University of Graz

View Trial →

NCT07510087

Recruiting

Glaucoma Related Quality of Life

Hyperbaric Oxygen Therapy for Optic Neuropathies

NCT07075718 Phase 2, Phase 3

Recruiting

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma

Enrollment

60 pts

Location

Honduras, United Kin...

Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

Rocklatan vs Latanoprost Post-DSLT

Eye Centers of Southeast Texas

View Trial →

NCT01957267

Recruiting

Functional and Structural Imaging for Glaucoma

Oregon Health and Science Univ...

View Trial →

NCT06991712 Phase 2

Recruiting

Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients

Christopher Kai Shun Leung

View Trial →

NCT06882356

Recruiting

The Glaucoma and Retinopathy Screening Study

Massachusetts Eye and Ear Infi...

View Trial →

Related Conditions

glaucoma open angle (1) cataract (1) optic neuropathy (1) open angle glaucoma (1) ocular hypertension (1) glaucoma suspect (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology